The U.S. Food and Drug Administration (FDA) recently issued a new safety alert regarding the increased risk of Fournier’s gangrene among diabetes patients using Invokana and other drugs in the same class. Fournier’s gangrene is considered to be a rare, but very serious complication of SGLT2 inhibitors. This condition is... Read more »

A Mississippi man has filed a federal lawsuit against Janssen Pharmaceuticals that alleges that the defendant’s negligence caused him to suffer from severe, permanent medical complications. Jim Dedeaux was prescribed Invokana by his physician, a diabetes medication manufactured by the defendant. He took it as prescribed, assuming from the information... Read more »

Severe side effects of Invokana – part of a new class of diabetes drugs manufactured by J&J – have prompted a wave of litigation filed throughout the United States. Most of the Invokana lawsuits have been centralized in New Jersey federal court under MDL # 2750 for more efficient pretrial... Read more »

A plaintiff claims that use of diabetes drug Invokana led to kidney failure. The plaintiff only took the medication for two months before she began having life-threatening side effects that forced her to stop taking Invokana and seek medical treatment for her kidney problems. Judith Buchanan filed her lawsuit on September 16 in... Read more »

A woman that developed ketoacidosis after taking the diabetes drug Invokana has filed a lawsuit against the drug’s manufacturers. Sheryl Desalis is claiming in her complaint that Janssen Pharmaceuticals, Johnson & Johnson and Mitsubishi Tanabe Pharma failed to provide proper warnings about the risks of diabetic ketoacidosis associated with their... Read more »

The U.S. Food and Drug Administration has issued a new safety alert regarding the type 2 diabetes drug canagliflozin — Invokana and Invokamet. The Agency issued a safety announcement on May 18, notifying patients and the medical community that results of an ongoing clinical trial revealed a higher number of... Read more »

Metabolic acidosis is a risk associated with Invokana that was recently highlighted in a report by the Institute for Safe Medical Practices (ISMP). Invokana is one of the drugs recently touted for its ability to manage type 2 diabetes, but potential side effects have raised concerns and led to a... Read more »

The drug Invokana belongs to a class of Type II diabetes medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, and is referred to generically as canagliflozin. This class of drugs, which also includes well-known brands like Farxiga, Xigdua XR, Jardiance and Glyxambi, was once highly-touted as an innovative alternative for Type II... Read more »

The FDA has issued a safety communication involving potentially dangerous side effects associated with a category of type 2 diabetes drugs known as SGLT2 inhibitors. The agency has warned that use of the drug could lead to ketoacidosis, a serious condition often requiring emergency medical care. Urinary tract infections or... Read more »

A plaintiff who recently filed a lawsuit against Invokana manufacturers Janssen Pharmaceuticals and Johnson & Johnson claims use of the drug to treat type 1 diabetes led to serious kidney damage. The lawsuit further accuses the companies of failing to warn consumers and the medical community about the risk associated with... Read more »